Н. В. Хромова

657 total citations
21 papers, 422 citations indexed

About

Н. В. Хромова is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Н. В. Хромова has authored 21 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Н. В. Хромова's work include Cancer Cells and Metastasis (7 papers), Mesenchymal stem cell research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Н. В. Хромова is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Mesenchymal stem cell research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Н. В. Хромова collaborates with scholars based in Russia, Sweden and United States. Н. В. Хромова's co-authors include Pavel Kopnin, Kopnin Bp, Е. В. Степанова, Larissa S. Agapova, V. L Zorin, I. I Eremin, A. Yu. Fedotov, В. С. Комлев, Vera B. Dugina and A. Yu. Teterina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and ACS Applied Materials & Interfaces.

In The Last Decade

Н. В. Хромова

16 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Н. В. Хромова Russia	8	208	128	102	99	56	21	422
Julia Bar Poland	13	207 1.0×	135 1.1×	93 0.9×	77 0.8×	48 0.9×	46	524
Sin‐Hye Oh South Korea	12	212 1.0×	62 0.5×	106 1.0×	61 0.6×	40 0.7×	24	445
Roberta Montella Italy	6	155 0.7×	91 0.7×	62 0.6×	58 0.6×	31 0.6×	6	365
Lisiane Bernardi Brazil	10	184 0.9×	159 1.2×	40 0.4×	89 0.9×	37 0.7×	25	495
Panimaya Jeffreena Miranda Australia	8	441 2.1×	140 1.1×	89 0.9×	236 2.4×	38 0.7×	12	681
Congchong Yang China	7	195 0.9×	180 1.4×	45 0.4×	105 1.1×	118 2.1×	8	388
Nicole Stuendl Austria	15	223 1.1×	108 0.8×	58 0.6×	88 0.9×	35 0.6×	17	456
Masud Khan Japan	9	500 2.4×	271 2.1×	76 0.7×	148 1.5×	57 1.0×	14	683
Jelena Kocić Serbia	12	285 1.4×	86 0.7×	30 0.3×	87 0.9×	65 1.2×	20	558
A V Rousselle France	8	285 1.4×	197 1.5×	68 0.7×	59 0.6×	40 0.7×	8	467

Countries citing papers authored by Н. В. Хромова

Since Specialization

Citations

This map shows the geographic impact of Н. В. Хромова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Н. В. Хромова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Н. В. Хромова more than expected).

Fields of papers citing papers by Н. В. Хромова

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Н. В. Хромова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Н. В. Хромова. The network helps show where Н. В. Хромова may publish in the future.

Co-authorship network of co-authors of Н. В. Хромова

This figure shows the co-authorship network connecting the top 25 collaborators of Н. В. Хромова. A scholar is included among the top collaborators of Н. В. Хромова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Н. В. Хромова. Н. В. Хромова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galembikova, Aigul, et al.. (2025). Hypoxia-Inducible Factor-1α, a Novel Molecular Target for a 2-Aminopyrrole Derivative: Biological and Molecular Modeling Study. Cancers. 18(1). 115–115.

Dugina, Vera B., Galina Shagieva, Sergei Boichuk, et al.. (2025). Induction of Fibroblast-to-Myofibroblast Differentiation by Changing Cytoplasmic Actin Ratio. Biochemistry (Moscow). 90(2). 289–298.

Хромова, Н. В., et al.. (2024). Fibro-adipogenic progenitor cells in skeletal muscle unloading: metabolic and functional impairments. Skeletal Muscle. 14(1). 31–31. 1 indexed citations

Shagieva, Galina, Vera B. Dugina, Anton V. Burakov, et al.. (2024). Divergent Contribution of Cytoplasmic Actins to Nuclear Structure of Lung Cancer Cells. International Journal of Molecular Sciences. 25(24). 13607–13607.

Хромова, Н. В., et al.. (2024). The effect of <i>NOTCH1</i> knockdown on the phenotype of human lung and colon cancer stem cells. SHILAP Revista de lepidopterología. 11(2). 97–105. 1 indexed citations

Хромова, Н. В., Vera B. Dugina, D.А. Kudlаy, et al.. (2024). Actin-Dependent Mechanism of Tumor Progression Induced by a Dysfunction of p53 Tumor Suppressor. Cancers. 16(6). 1123–1123. 1 indexed citations

Dugina, Vera B., Н. В. Хромова, Svetlana Vinokurova, et al.. (2024). Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 25(8). 4530–4530. 3 indexed citations

Хромова, Н. В., et al.. (2022). Significance of NOTCH1 Expression in the Progression of Human Lung and Colorectal Cancers. Biochemistry (Moscow). 87(10). 1199–1205. 3 indexed citations

Хромова, Н. В., et al.. (2017). A change in the expression of membrane-associated proteins and cytoplasmic actin isoforms in the progression of human colon tumors. Russian Journal of Archive of Pathology. 79(2). 15–15. 3 indexed citations

10.

Хромова, Н. В., et al.. (2017). Components of the hepatocellular carcinoma microenvironment and their role in tumor progression. Biochemistry (Moscow). 82(8). 861–873. 82 indexed citations

11.

Zorin, V. L, et al.. (2017). Myogenic potential of human alveolar mucosa derived cells. Cell Cycle. 16(6). 545–555. 8 indexed citations

12.

Хромова, Н. В., et al.. (2016). E-CADHERIN EXPRESSION DOWNREGULATION ELEVATES TUMOROGENIC POTENTIAL OF HUMAN COLON CANCER CELL LINE HCT116 VIA INCREASE IN CANCER STEM CELLS AMOUNT. Russian Journal of Biotherapy. 15(3). 6–14. 2 indexed citations

13.

Хромова, Н. В., et al.. (2016). E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth. Cell Cycle. 15(8). 1084–1092. 28 indexed citations

14.

Хромова, Н. В., et al.. (2015). THE ROLE OF NOTCH PATHWAY IN CARCINOGENESIS. SHILAP Revista de lepidopterología. 2(3). 30–42.

15.

Хромова, Н. В., et al.. (2015). THE ROLE OF EPITHELIAL-MESENCHYMAL TRANSITION IN REGULATION OF SOLID TUMORS CANCER STEM CELLS CHARACTERISTICS. Russian Journal of Biotherapy. 14(4). 3–8. 2 indexed citations

16.

Zorin, V. L, В. С. Комлев, Н. В. Хромова, et al.. (2014). Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts. Biomedical Materials. 9(5). 55005–55005. 28 indexed citations

17.

Комлев, В. С., С. М. Баринов, I. Y Bozo, et al.. (2014). Bioceramics Composed of Octacalcium Phosphate Demonstrate Enhanced Biological Behavior. ACS Applied Materials & Interfaces. 6(19). 16610–16620. 77 indexed citations

18.

Хромова, Н. В., et al.. (2013). Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21^Cip1/WAF1pathways. Cell Cycle. 12(5). 826–836. 42 indexed citations

19.

Хромова, Н. В., et al.. (2011). Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene. 31(11). 1389–1397. 64 indexed citations

20.

Хромова, Н. В., Pavel Kopnin, Е. В. Степанова, Larissa S. Agapova, & Kopnin Bp. (2008). p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Letters. 276(2). 143–151. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact